Meropenem Kabi

Meropenem, the active ingredient in Meropenem Kabi, is a carbapenem antibiotic presented as an injection solution for intravenous use. It treats serious bacterial infections in hospitalized patients.

GNH USA supplies Meropenem Kabi as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is used to treat severe bacterial infections across several organ systems.

- Complicated intra-abdominal infections: provides broad‑spectrum coverage against Gram‑negative, Gram‑positive and anaerobic pathogens. - Complicated urinary tract infections: eradicates resistant Enterobacteriaceae and other uropathogens. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat susceptible organisms. - Hospital‑acquired pneumonia: targets multidrug‑resistant Gram‑negative bacteria. - Skin and soft‑tissue infections: effective against mixed aerobic and anaerobic flora.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Diarrhea: mild to moderate gastrointestinal upset. - Nausea: occasional feeling of queasiness. - Rash: transient skin erythema. - Elevated liver enzymes: transient increase in transaminases. - Injection site pain: discomfort at the infusion site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: particularly in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe intestinal infection. - Thrombocytopenia: marked reduction in platelet count. - Renal dysfunction: acute kidney injury in susceptible individuals.

Meropenem should be used with careful clinical assessment and monitoring.

- Renal function: adjust dose in patients with impaired clearance. - CNS disorders: monitor for neurotoxicity, especially seizures. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Allergies: avoid in patients with known carbapenem hypersensitivity. - Concomitant antibiotics: assess for additive toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Valproic acid: concurrent use can reduce valproate levels, risking seizure breakthrough. - Probenecid: may increase meropenem plasma concentrations, heightening toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxicity; monitor renal function. - Loop diuretics: may enhance ototoxic potential when used together. - Anticoagulants (e.g., warfarin): possible alteration of INR; check coagulation parameters.